Development and validation of a UPLC-MS/MS method for almonertinib with its active metabolite HAS-719 and anlotinib in human plasma
1. 系统已在2025-07-08 11:53:54对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.jpba.2025.116766
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0731708525001074
其他信息:
出版社: Elsevier BV
作者: Yi Qin; Xiaojun Guan; Shichao Zhang; Zijie Zhang; Chenrong Huang; Liyan Miao